tiprankstipranks

Sherrill Neff Insider Profile

4 Followers
Sherrill Neff, Director at Melinta Therapeutics, holds 25.45K shares in ACRES Commercial Realty (Ticker: ACR), holds 1.29M shares in Tobira Therapeutics (Ticker: TBRA), holds 3.53M shares in Melinta Therapeutics (Ticker: MLNTQ).
tipranks
Sherrill Neff

Sherrill Neff
Melinta Therapeutics (MLNTQ)
Director

Ranked #76,584 out of 99,541 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

-17.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
97.78%
2.22%
A breakdown of Sherrill Neff's holdings

Insider Roles

Amicus
(FOLD)
Director
ACRES Commercial Realty
(ACR)
Director
Roles that Sherrill Neff holds in companies

Most Profitable Insider Trade

Stock:
Melinta Therapeutics
(MLNTQ)
Rating:Informative Buy
Date:Feb 09, 2012 - Feb 09, 2013
Return:+8.70%
The most profitable trade made by Sherrill Neff

Sherrill Neff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MLNTQ
Melinta Therapeutics
Aug 01, 2013
Informative Buy
1.85M
$387.99K
TBRA
Tobira Therapeutics
Aug 29, 2013
Uninformative Buy
$54.47M
ACRES Commercial Realty
May 08, 2024
Director
Uninformative Buy
$327.55K
Amicus
Director
$14.40M
List of latest transactions for each holding click on a transaction to see Sherrill Neff's performance on stock

Sherrill Neff insider profile FAQ

What is the percentage of profitable transactions made by Sherrill Neff?
The percentage of profitable transactions made by Sherrill Neff is 60%.
    What is the average return per transaction made by Sherrill Neff?
    The average return per transaction made by Sherrill Neff is -17.80%.
      What stocks does Sherrill Neff hold?
      Sherrill Neff holds: MLNTQ, TBRA, ACR, FOLD stocks.
        What was Sherrill Neff’s latest transaction?
        Sherrill Neff latest transaction was an Uninformative Buy of ―.
          What was Sherrill Neff's most profitable transaction?
          Sherrill Neff’s most profitable transaction was an Informative Buy of MLNTQ stock on February 9, 2012. The return on the trade was 8.70%.
            What is Sherrill Neff's role in Melinta Therapeutics?
            Sherrill Neff's role in Melinta Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.